BJDX - CIK 0001704287
The table below shows Bluejay Diagnostics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $811.84K | $785.61K | $889.90K | $784.80K | $551.65K | $1.03M |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.13M |
| $831.34K |
| $1.10M |
| $1.10M |
| $809.20K |
| $862.48K |
| Operating income | -$1.94M | -$1.62M | -$1.99M | -$1.89M | -$1.36M | -$1.90M |
| Income tax | - | - | - | - | - | - |
| Net income | -$1.92M | -$1.60M | -$1.96M | -$1.86M | -$1.48M | -$2.48M |
| EPS (diluted) | -$1.95 | -$1.01 | -$1.41 | -$13.46 | -$76.94 | -$256.16 |